Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Nature's Sunshine Products, Inc. - Common Stock (NQ:NATR)

15.54 -0.05 (-0.32%)
Streaming Delayed Price Updated: 11:06 AM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nature's Sunshine Products, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Why Nature's Sunshine (NATR) Shares Are Getting Obliterated Today
Shares of wellness products company Nature’s Sunshine (NASDAQ:NATR) fell 8.5% in the afternoon session after the company announced the pricing of a secondary stock offering by a major shareholder. The... 
Via StockStory
1 Cash-Producing Stock with Solid Fundamentals and 2 to Avoid
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
1 Safe-and-Steady Stock with Exciting Potential and 2 to Question
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Why Nature's Sunshine (NATR) Shares Are Falling Today
Shares of wellness products company Nature’s Sunshine (NASDAQ:NATR) fell 7.2% in the morning session after CEO Terrence Moorehead, announced his decision to step down from his role. The board also... 
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For May 6, 2025
Via Benzinga
3 Inflated Stocks in Hot Water
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to new product launches, positive news, or even a dedicated social media... 
Via StockStory
NATR Q1 Earnings Call: Outperformance Driven by Asia-Pacific and Europe Amid Tariff Uncertainty
Wellness products company Nature’s Sunshine (NASDAQ:NATR) announced better-than-expected revenue in Q1 CY2025, with sales up 2% year on year to $113.2 million. The company expects the full year’s... 
Via StockStory
Topics Economy World Trade
3 Consumer Stocks with Mounting Challenges
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. Surprisingly, the sector hasn’t played its shielding role over the past six months as it tumbled 10.5%. This... 
Via StockStory
Topics Stocks
Q1 Earnings Outperformers: Nature's Sunshine (NASDAQ:NATR) And The Rest Of The Personal Care Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at personal care stocks, starting with... 
Via StockStory
Topics Economy
1 of Wall Street’s Favorite Stock to Keep an Eye On and 2 to Be Wary Of
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Nature's Sunshine (NASDAQ:NATR) Beats Q1 Sales Targets
Wellness products company Nature’s Sunshine (NASDAQ:NATR) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2% year on year to $113.2 million. The company expects the... 
Via StockStory
Nature's Sunshine (NATR) Reports Q1: Everything You Need To Know Ahead Of Earnings
Wellness products company Nature’s Sunshine (NASDAQ:NATR) will be announcing earnings results tomorrow after market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
3 Cash-Heavy Stocks in the Doghouse
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining... 
Via StockStory
Winners And Losers Of Q4: Nature's Sunshine (NASDAQ:NATR) Vs The Rest Of The Personal Care Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the personal care stocks, including Nature's Sunshine (NASDAQ:NATR) and its peers. 
Via StockStory
Topics Economy
Personal Care Stocks Q4 Results: Benchmarking Medifast (NYSE:MED)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at personal care stocks, starting with... 
Via StockStory
Topics Economy
3 Reasons to Sell NATR and 1 Stock to Buy Instead
Although the S&P 500 is down 1.6% over the past six months, Nature's Sunshine’s stock price has fallen further to $11.31, losing shareholders 14.1% of their capital. This was partly due to its softer... 
Via StockStory
Topics Stocks
3 Small-Cap Stocks Skating on Thin Ice
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
3 Consumer Stocks in Hot Water
Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. But recently, the industry has failed to do its job as it shed 9.5% over the past six months.... 
Via StockStory
Topics Stocks
Unpacking Q4 Earnings: BeautyHealth (NASDAQ:SKIN) In The Context Of Other Personal Care Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including BeautyHealth (NASDAQ:SKIN) and its peers. 
Via StockStory
Topics Economy
Q4 Earnings Highs And Lows: Coty (NYSE:COTY) Vs The Rest Of The Personal Care Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Coty (NYSE:COTY) and its peers. 
Via StockStory
Topics Economy
Nature's Sunshine (NASDAQ:NATR) Beats Q4 Sales Targets
Wellness products company Nature’s Sunshine (NASDAQ:NATR) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 8.5% year on year to $118.2 million. The company expects... 
Via StockStory
Earnings To Watch: Nature's Sunshine (NATR) Reports Q4 Results Tomorrow
Wellness products company Nature’s Sunshine (NASDAQ:NATR) will be reporting earnings tomorrow after market hours. Here’s what you need to know. 
Via StockStory
Nature's Sunshine (NATR): Buy, Sell, or Hold Post Q3 Earnings?
Nature's Sunshine currently trades at $14.37 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500’s 16.9% gain during... 
Via StockStory
Topics Stocks
Earnings Scheduled For March 11, 2025
Via Benzinga
Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
1 Consumer Stock to Hold Forever and 2 to Dump
Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. On the other hand, they usually underperform during bull runs, but the sector has bucked this trend... 
Via StockStory
Topics Stocks
Reflecting On Personal Care Stocks’ Q3 Earnings: Inter Parfums (NASDAQ:IPAR)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Inter Parfums (NASDAQ:IPAR) and... 
Via StockStory
Topics Economy
Spotting Winners: Nu Skin (NYSE:NUS) And Personal Care Stocks In Q3
Let’s dig into the relative performance of Nu Skin (NYSE:NUS) and its peers as we unravel the now-completed Q3 personal care earnings season. 
Via StockStory
Topics Economy
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.